113 related articles for article (PubMed ID: 4261143)
1. Streptozotocin in the treatment of cancer: phase II study.
Strolinsky DC; Sadoff L; Braunwald J; Bateman JR
Cancer; 1972 Jul; 30(1):61-7. PubMed ID: 4261143
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer.
Talley RW; Samson MK; Brownlee RW; Samhouri AM; Fraile RJ; Baker LH
Eur J Cancer (1965); 1981 Mar; 17(3):337-43. PubMed ID: 6455296
[No Abstract] [Full Text] [Related]
3. Streptozotocin therapy in 22 cancer patients.
DuPriest RW; Huntington MC; Massey WH; Weiss AJ; Wilson WL; Fletcher WS
Cancer; 1975 Feb; 35(2):358-67. PubMed ID: 122912
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of hexamethylmelamine (NSC 13875).
Wilson WL; Schroeder JM; Bisel HF; Mrazek R; Hummel RP
Cancer; 1969 Jan; 23(1):132-6. PubMed ID: 5812585
[No Abstract] [Full Text] [Related]
5. Toxicity study of BCNU (NSC-409962) given orally.
Lessner HE; Vogler WR
Cancer Chemother Rep; 1974; 58(3):407-11. PubMed ID: 4601671
[No Abstract] [Full Text] [Related]
6. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.
Broder LE; Carter SK
Ann Intern Med; 1973 Jul; 79(1):108-18. PubMed ID: 4352784
[No Abstract] [Full Text] [Related]
7. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).
Schein PS; O'Connell MJ; Blom J; Hubbard S; Magrath IT; Bergevin P; Wiernik PH; Ziegler JL; DeVita VT
Cancer; 1974 Oct; 34(4):993-1000. PubMed ID: 4371075
[No Abstract] [Full Text] [Related]
8. Search for new cancer drugs: streptozotocin.
Du Priest RW; Massey WH; Fletcher WS
Am Surg; 1972 Sep; 38(9):514-20. PubMed ID: 4341764
[No Abstract] [Full Text] [Related]
9. Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature.
Schein P; Kahn R; Gorden P; Wells S; Devita VT
Arch Intern Med; 1973 Oct; 132(4):555-61. PubMed ID: 4355081
[No Abstract] [Full Text] [Related]
10. Patterns of intravenous glucose tolerance and insulin response before and after treatment with streptozotocin (NSC-85998) in patients with cancer.
Sadoff L
Cancer Chemother Rep; 1972 Feb; 56(1):61-9. PubMed ID: 4260577
[No Abstract] [Full Text] [Related]
11. Phase I studies on chlorozotocin.
Hoth D; Woolley P; Green D; Macdonald J; Schein P
Clin Pharmacol Ther; 1978 Jun; 23(6):712-22. PubMed ID: 148344
[TBL] [Abstract][Full Text] [Related]
12. [Association of antineoplastic agents in the treatment of lung neoplasms. A study of 173 cases].
Decroix G; Sors C
Sem Hop; 1968 Nov; 44(48):2933-9. PubMed ID: 4305734
[No Abstract] [Full Text] [Related]
13. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
[TBL] [Abstract][Full Text] [Related]
14. [Complications of antibiotic therapy].
Cah Med; 1971 Dec; 12(17):1527-38. PubMed ID: 5149498
[No Abstract] [Full Text] [Related]
15. [Streptozotocin and malignant insulinomas. Apropos of the case. Review of the literature].
Beylot J; Veyret V; Vallat I; Longy M; Moretti G
Sem Hop; 1976 Feb; 52(8):489-96. PubMed ID: 184544
[TBL] [Abstract][Full Text] [Related]
16. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
Rege VB; Owens AH
Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668
[No Abstract] [Full Text] [Related]
17. Phase I trial of chlorozotocin.
Gralla RJ; Tan CT; Young CW
Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of antibiotics.
Cunha BA; Ristuccia AM
Heart Lung; 1984 Sep; 13(5):465-72. PubMed ID: 6236175
[No Abstract] [Full Text] [Related]
19. Clinical and pathological effects of streptozotocin.
Loftus L; Cuppage FE; Hoogstraten B
J Lab Clin Med; 1974 Sep; 84(3):407-13. PubMed ID: 4368506
[No Abstract] [Full Text] [Related]
20. Phase II study of chlorozotocin in malignant melanoma: a Southeastern Cancer Study Group report.
Van Amburg AL; Presant CA; Burns D
Cancer Treat Rep; 1982 Jun; 66(6):1431-3. PubMed ID: 6211234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
